Recommendations for Method Development and Validation of qPCR and dPCR Assays in Support of Cell and Gene Therapy Drug Development A new paper, with contributions
TATAA Research Spotlight New paper from Nature.com – ‘Predicting sepsis using a combination of clinical information and molecular immune markers sampled in the ambulance’ (In
New qPCR and sequencing paper using TATAA GrandScript cDNA FreePrime kit. qPCR assays with hydrolysis probe were designed by TATAA Biocenter.
Field experts have published the study Protein Biomarkers of New-Onset Heart Failure: Insights From the Heart Omics and Ageing Cohort, the Atherosclerosis Risk in Communities Study, and the Framingham Heart Study.
Congratulations to Merve Keles obtaining his PhD with the thesis “Secreted long non-coding RNAs Gadlor1 and Gadlor2 act as mediators of cardiac remodelling during pressure overload”, where TATAA’s RNA spikes were successfully used as exogeneous controls.
Patent for the Two-Tailed PCR technology invented by TATAA Biocenter has been granted in the United States.
"*" indicates required fields
TATAA Biocenter AB © 2024 All rights reserved
"*" indicates required fields
"*" indicates required fields
"*" indicates required fields
"*" indicates required fields
"*" indicates required fields
"*" indicates required fields
